Menopause proteomics were consistently associated with inflammatory brain aging and Alzheimer’s dementia risk across nearly 15,000 women in a new study published in Nature Medicine.
|Articles|February 1, 2005
Liability surcharges get AMA backing
The American Medical Association's board of trustees endorsed a new policy supporting the right of physicians to charge patients an extra fee to offset the rising cost of medical liability insurance. The tactic is being implemented by physicians in a few states in response to the medical liability crisis.
Advertisement
Advertisement
Related to this article
The FDA approved an IDE allowing Mercy BioAnalytics to evaluate its Evident blood-based ovarian cancer screening test in the prospective pivotal SOARA study of average-risk women.
Sameena Rahman, MD, discusses how digital symptom trackers can shorten PMOS diagnostic delays and support earlier cardiometabolic care.
A new, expert-led video series explores the PCOS-to-PMOS rename and what it means for diagnosis, care, and outcomes.
Seventy-one percent of women miss their first perimenopausal symptom because anxiety, brain fog, and mood changes precede hot flashes—and most attribute them to stress, per the Bonafide 2026 State of Menopause Survey.
A real-world study presented at Psych Congress found that zuranolone's PPD symptom improvements were sustained through day 90.
Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.
Maternal RSV immunization creates an important opportunity for obstetric and pediatric clinicians to coordinate newborn prevention strategies, according to Kevin Ault, MD.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Zuranolone shows sustained PPD symptom improvement through day 90
2
Q&A: Sameena Rahman, MD, on digital symptom tracking in PMOS
3
Emotional and cognitive symptoms are redefining perimenopause recognition
4
FDA approves IDE for pivotal study of Evident ovarian cancer screening test
5